The Drug Science Podcast

The Drug Science Podcast

116 episodes

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.

91. The Psychedelic Industry with Josh Hardman

Nov, 23, 2023
In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and...

90. Investing in Psychedelics with Dustin Robinson

Nov, 08, 2023
In this episode, Prof Jo Neill and Dr Hannah Thurgur sit down with Dustin Robinson, the visionary founding partner of Mr. Cannabis Law and a co-founder of Mr. Psychedelics Law. These law firms possess the expertise needed to navigate the intricate and strictly regulated realms of cannabis and...
MDMA Cannabis Psychedelics

89. David Vs David with Dr David Erritzoe

Oct, 25, 2023
Recorded live from the launch event of David Nutt's latest book, "Psychedelics: The Revolutionary Drugs That Could Change Your Life – a guide from the expert," in this episode Dr. David Erritzoee and David Nutt engage in a discussion about Psychedelics. During the conversation, David Nutt provides...
Psilocybin MDMA Psychedelics

88. Psychonauts with Mike Jay

Oct, 11, 2023
In this episode, Mike Jay explores the contents of his latest book titled "Psychonaut," which offers a thought-provoking and unique account of the scientists, writers, artists, and philosophers who engaged in drug exploration to uncover the enigmatic realms of the mind. The podcast delves into the...

87. Mental Health in Academia with Dr Meg Spriggs

Sep, 27, 2023
In this episode, Meg Spriggs shares her firsthand experience dealing with the challenges mental health while pursuing her studies in academia. She candidly talks about the difficulties she faced with anorexia and mood disorders which led to her investigating the potential of psilocybin for treating...

86. Diamorphine Assisted Treatment with Danny Ahmed

Sep, 13, 2023
In this episode, Jo Neil, and Hannah Thurger are joined by Danny Ahmed, a highly experienced Registered Mental Health Nurse and Integrated Psychotherapist with over two decades of expertise. Together, they delve into a comprehensive discussion on a variety of harm reduction techniques.  Throughout...

85. MDMA, Ketamine and Cannabis with Prof Valerie Curran

Aug, 30, 2023
In this episode, Professr Valerie Curran, discusses the psychological effects of drugs that act on the human brain.  Valerie Curren holds the position of Professorial Fellow in the Neuroscience of Addiction and Mental Health Program at ACU's Healthy Brain and Mind Research Centre. She has an...
Psilocybin Ketamine Cannabis

84. Will DMT be a medicine in the UK? with Dr Carol Routledge

Aug, 16, 2023
Join us for an insightful episode featuring Dr. Carol Routledge, a distinguished senior scientist and the Chief Medical and Scientific Officer at Small Pharma Labs. Dr. Routledge takes us on a journey through her remarkable career path that ultimately led her to work at Small Pharma. With a wealth...

83. Australia medicalises MDMA and psilocybin with Peter Hunt

Aug, 02, 2023
In this episode, Peter Hunt discusses the journey which led himself and his wife co-founding Mind Medicine in Australia. Mind Medicine work to alleviate the suffering and suicides caused by mental illness in Australia through expanding the treatment options available to medical practitioners and...
Psilocybin MDMA

82. Psychedelics in Europe with Tadeusz Hawrot and Frédéric Destrebecq

Jul, 19, 2023
This weeks Podcast features Frédéric Destrebecq and Tadeusz Hawrot as they discuss the latest developments in research and clinical development with psychedelics in Europe. Frédéric Destrebecq is the Executive Director of the European Brain Council (EBC), a non-profit organization based in...
MDMA Psychedelics

81. Head Injury, Professional Rugby and Psychedelics with Rory Lamont

Jul, 05, 2023
This weeks podcast features Rory Lamont, a former professional Rugby Union player, as he discusses his experiences discovering the transformative healing potential of plant medicines such as Iboga and Ayahuasca. During the 2012 Six Nations tournament, while playing for Scotland, Rory suffered a...
Iboga Psychedelics

80. Cannabis for Epilepsy with Dr Evan Lewis

Jun, 21, 2023
In this week's episode of the Drug Science Podcast, Prof Nutt and Dr Thurgur are joined by Dr Evan Lewis of Numinus! Dr. Evan Lewis is a Paediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), tele-neurology and medical...

79. Smoking vs Vaping with Dr Alex Wodak

Jun, 07, 2023
In this week’s episode, join Professor David Nutt as he engages in a thought-provoking conversation with Dr Alex Wodak, an internationally renowned authority on harm reduction and the esteemed president of the Australian Drug Law Reform Foundation. With a rich background as the former director of...

78. Are Psychedelics Anti-inflammatory? with Dr Charles Nichols

May, 24, 2023
Join us on this enlightening episode of the Drug Science podcast as we delve into the fascinating world of serotonergic pathways and their potential applications in treating psychiatric disorders and combating inflammation. Our special guest, Charles Nichols, a distinguished professor of...
LSD Psychedelics

77. Is Depression Evolutionary? with Dr Charles Raison

May, 10, 2023
Is depression evolutionary? Is inflammation good or bad? Can sleep be bad for you? Tune in to find out.    Depression is a complex and debilitating mental health disorder that affects millions of people worldwide. Despite the prevalence of depression, its causes and origins are still not entirely...
Psilocybin Psychedelics

76. What is Decriminalisation? with Kassandra Frederique

Apr, 26, 2023
Are you curious about the impact of drug policies on marginalized communities? Then tune in to this week's episode of our podcast! Our guest, Kassandra Frederique, the Executive Director of the Drug Policy Alliance, joins Dr. Hannah Thurgur to discuss the impact of drug policies on Black, Latino,...

T21 - Medical Cannabis bonus episode

Apr, 20, 2023
T21 (formerly Project Twenty21) is a pioneering medical cannabis registry launched in the United Kingdom in 2019. It aims to create the UK's largest body of evidence for the effectiveness and tolerability of medical cannabis in treating a range of conditions. T21 focuses on patients with conditions...

75. DMT for Depression with Dr Graham Campbell

Apr, 12, 2023
Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field. Drawing from his extensive...
Psilocybin DMT

74. Welcome to Season 4 with Dr Thurgur and Prof Neill

Mar, 29, 2023
Welcome to season 4 of the Drug Science Podcast! In this episode, we're introducing our new hosts: Professor Jo Neill and Dr Hannah Thurgur!    Jo Neill is a professor of psychopharmacology at the University of Manchester and the chair of the Medical Psychedelics Working Group of Drug Science....

Drug Science LIVE - Part 2

Mar, 15, 2023
This week we present you with part 2 of the podcast recorded live at the book launch of 'Drug Science and British Drug Policy’. We’re going to hear panel discussions on the Misuse of Drugs Act 1971 and different approaches to drug policy with co-authors of the book. This time, professor David...